4.100 s

+0.090 (+2.24%)
Range 3.900 - 4.360   (11.79%)
Open 4.090
Previous Close 4.010
Buy Price 3.960
Buy Volume 10
Sell Price 4.100
Sell Volume 12
Volume 417,154
Value -
Remark s
Measurement Type Value
EPS (USD) -0.326
Trailing EPS (USD) -0.326
NAV (USD) 3.32
Cash In Hand (USD) 3.228
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 1.226
Price / Cash In Hand 1.261
Issued & Paid-up Shares 6,992,240
Treasury Shares -
Market Cap (M) 28.458
Par Value (USD) n.a.
Beta - 75 Days 1.374
R-Squared - 75 Days(%) 18.65
Beta - 500 Days 1.75
R-Squared - 500 Days(%) 3.39
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 28 May 2022 04:00.
Data powered by
View All Events


NeuroMetrix, Inc. (NeuroMetrix) is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company is in the position to address these unmet needs through the development of medical devices. The Company intends to advance its objectives in the diabetic neuropathy market include: Driving Commercial Adoption of Products for Diabetic Neuropathy in the United States. The Company develops and market neurodiagnostic systems, which typically consists of a medical device plus single patient-use biosensors or electrodes.The Company�s NC-stat DPNCheck consists of an electronic hand-held device and a single patient use biosensor. More than 1.7 million patient studies have been performed using the Company's NC-stat technology and there have been approximately 6.3 million nerve tests, including nearly 700,000 sural nerve tests.

Loading Chart...